Moderna To Collaborate With Mitsubishi On Respiratory Vaccine Promotion In Japan

Moderna (NASDAQ:MRNA) and Mitsubishi Tanabe Pharma Corporation have signed a joint agreement regarding the co-promotion of Moderna’s mRNA respiratory vaccine portfolio in Japan.

The Details: Moderna will solely control the the manufacturing, sales, medical education and distribution of its mRNA respiratory vaccines, however, both companies will work to enable broad access to Moderna’s mRNA respiratory vaccine portfolio in Japan.

“Mitsubishi Tanabe Pharma has a significant heritage in Japan and has long contributed to public health through numerous vaccines and possesses extensive experience and deep knowledge in this area,” said Kazumasa Nagayama, president and representative director of Moderna Japan.

“We look forward to working together to provide our COVID-19 vaccine in Japan, given the virus continues to pose a significant threat to public health.”

The contract has an initial term which runs till March 31, 2029.

How To Buy Moderna Stock

By now you're likely curious about how to participate in the market for Moderna (NASDAQ:MRNA) – be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.

In the the case of Moderna (NASDAQ:MRNA), which is trading at $115.86 as of publishing time, $100 would buy you 0.86 shares of stock.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

MRNA Price Action: Moderna shares are trading 0.63% higher at $117.19, according to data from Benzinga Pro.

Image: Photo via Shutterstock

MRNAModerna Inc

$52.53-0.06%

Overview

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.